HI
DXCM icon

HBK Investments’s DexCom DXCM Stock Holding History

HBK Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,500
Closed -$1.26M – 228
2023
Q3 		$1.26M Buy
13,500
+6,700
+99% +$755K 0.01% 178
2023
Q2 		$874K Buy
+6,800
New +$822K ﹤0.01% 285
2022
Q4 		– Sell
-3,500
Closed -$282K – 81
2022
Q3 		$282K Buy
+3,500
New +$296K ﹤0.01% 403

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HBK Investments's DXCM Position: Q4 2023 in Review

HBK Investments sold out of DexCom (DXCM) in Q4 2023, closing a stake of 88,307 shares — an estimated $8.24M sold.

HBK Investments first reported a position in DXCM in Q3 2013 and held it in 18 quarters. The position peaked at $8.24M in Q3 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • HBK Investments reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • HBK Investments sold 88,307 DexCom shares in Q4 2023, an estimated $8.24M.
  • HBK Investments first reported a position in DexCom in Q3 2013 and held it in 18 quarters.
  • HBK Investments's DexCom position peaked at $8.24M in Q3 2023.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on HBK Investments's 13F filing for Q4 2023, filed 14 Feb 2024.